top of page
利害關係人專區.jpg

Stakeholder Engagement-Key Issues & Communication Channels

Jia Jie Biomedical Co., Ltd. (the “Company”) fully recognizes that the opinions and expectations of stakeholders are critical to the Company’s sustainable development. Accordingly, the Company is committed to establishing diversified, transparent, and effective communication mechanisms. Through regular dialogue with different stakeholder groups, the Company ensures that external expectations are appropriately addressed in the course of sustainable operations, while continuously optimizing its operational strategies and ESG management framework.

In accordance with the AA1000 Stakeholder Engagement Standard (AA1000 SES), the Company identifies its key stakeholders based on five dimensions—dependency, responsibility, influence, diversity of perspectives, and tension of concerns. On this basis, the Company determines the primary stakeholders most relevant to its operations and establishes effective communication approaches to ensure that the engagement process is conducted with integrity, transparency, responsiveness, and continuity.

The stakeholder communication outcomes for 2024 were reported to the Board of Directors on August 5, 2025.

利害關係人Stakeholders
溝通、回應方式與頻率Communication, Response Methods & Frequency
關注議題Key Issues of Concern
114年利害關係人溝通實績Stakeholder Engagement Performance in 2025
Local Communities
■ (As needed) Community Contribution Programs ■ (As needed) Charitable Donations and Volunteer Activities ■ (As needed) Neighborhood Communication Meetings
1. Social Welfare and Community Engagement 2. Water Resource Management 3. Waste Management 4. Energy Management
■ Investment in community welfare programs ■ Environmental protection advocacy activities organized
Shareholders and Investors
■ (Quarterly) Quarterly Reports ■(Annually) Shareholders’ Meeting, Annual Report ■(Annually) Investor Conference ■(Real-time) Shareholder Services Hotline ■(Real-time) Company Website ■(Real-time) Market Observation Post System (MOPS) ■(Real-time) Investor Relations Contact Window
1. Corporate Governance 2. Regulatory Compliance 3. Ethical Management 4. Economic Performance 5. Product Responsibility and Innovative R&D
■ 29 Mandarin material information disclosures and 17 announcements ■ Monthly revenue announcements on MOPS, totaling 12 disclosures. ■ Quarterly financial reports announced on MOPS, totaling 2 disclosures. ■ 2 online investor conference held ■ One shareholders’ meeting convened ■ 7 Board of Directors meetings convened ■ Direct responses to shareholder inquiries through various communication channels
Employees
■(Quarterly) Occupational Safety and Health Committee ■(Real-time) Internal Grievance Hotline ■(Real-time) Internal Company Mailbox ■(Real-time) Internal Information System Announcements ■(As needed) Labor–Management Meetings ■(As needed) Employee Welfare Committee ■(As needed) Labor Union ■(As needed) Education and Training
1. Economic Performance 2. Talent Development and Training 3. Occupational Health and Safety 4. Information Security, Customer Privacy, and Internal Control 5. Labor Rights Equality and Labor Relations
■ Four labor–management meetings convened ■ Employee grievance mailbox provided ■ Internal talent development programs implemented ■ Regular health consultations and follow-ups provided to ensure employee health management needs ■ On-site medical personnel services provided on an irregular basis ■ Internal announcements issued from time to time regarding employee benefits, Welfare Committee information, major operational updates, and training-related information
Suppliers
■ (Annually) Supplier Conference ■ (As needed) Supplier Visits ■ (As needed) Supplier Evaluation and Audits ■ (As needed) Supplier Commitment Letters
1. Supplier Management 2. Product Quality and Safety
■ Supplier evaluations conducted ■ Green supply chain policies strengthened
Customers and Consumers
■ (Annually) Customer Satisfaction Survey ■ (Real-time) Company Website and Email ■ (As needed) Customer Service Hotline
1. Ethical Management 2. Customer Relationships 3. Product Responsibility and Innovative R&D
■ 208 customer satisfaction questionnaires collected, with an overall satisfaction rate of 83% and the highest evaluation received ■ 100% of customer complaints properly handled ■ Company website updated on an irregular basis
Government and Competent Authorities
■ (Annually) Annual Report and Sustainability Report ■ (As needed) Government Policy Meetings ■ (As required by competent authorities) Administrative correspondence ■ (In accordance with regulations) Periodic inspections by competent authorities
Regulatory Compliance
■ Participation in more than 12 policy and regulatory seminars, as well as internal and external training courses and workshops organized by government authorities ■ Participation in the Corporate Governance Evaluation ■ Irregular correspondence with government or competent authorities ■ Submission of ESG information disclosure reports in compliance with regulatory requirements
  • Facebook
  • YouTube

3F, No. 61, Jiuru 1st Road, Sanmin District, Kaohsiung City, Taiwan

3F., No.61, Jiuru 1st Rd., Sanmin Dist., Kaohsiung City 807, Taiwan

COPYRIGHT © 2025 - JiaJie Biomedical | ALL RIGHTS RESERVED

bottom of page